Works matching IS 17588340 AND DT 2016 AND VI 8 AND IP 3
Results: 9
Pemetrexed for advanced stage nonsquamous non-small cell lung cancer: latest evidence about its extended use and outcomes.
- Published in:
- Therapeutic Advances in Medical Oncology, 2016, v. 8, n. 3, p. 198, doi. 10.1177/1758834016644155
- By:
- Publication type:
- Article
Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in metastatic breast cancer: which benefit for which patients?
- Published in:
- Therapeutic Advances in Medical Oncology, 2016, v. 8, n. 3, p. 209, doi. 10.1177/1758834016639873
- By:
- Publication type:
- Article
The preoperative platelet–lymphocyte ratio versus neutrophil–lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma?
- Published in:
- Therapeutic Advances in Medical Oncology, 2016, v. 8, n. 3, p. 160, doi. 10.1177/1758834016638019
- By:
- Publication type:
- Article
Nintedanib in NSCLC: evidence to date and place in therapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2016, v. 8, n. 3, p. 188, doi. 10.1177/1758834016630976
- By:
- Publication type:
- Article
Phase II study of gemcitabine plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2016, v. 8, n. 3, p. 153, doi. 10.1177/1758834016637592
- By:
- Publication type:
- Article
Treatment approach in patients with hyperbilirubinemia secondary to liver metastases in gastrointestinal malignancies: a case series and review of literature.
- Published in:
- Therapeutic Advances in Medical Oncology, 2016, v. 8, n. 3, p. 144, doi. 10.1177/1758834016637585
- By:
- Publication type:
- Article
Ramucirumab in metastatic colorectal cancer: evidence to date and place in therapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2016, v. 8, n. 3, p. 230, doi. 10.1177/1758834016635888
- By:
- Publication type:
- Article
Overcoming resistance to first/second generation epidermal growth factor receptor tyrosine kinase inhibitors and ALK inhibitors in oncogene-addicted advanced non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2016, v. 8, n. 3, p. 176, doi. 10.1177/1758834016631531
- By:
- Publication type:
- Article
Immunotherapy for head and neck cancer: latest developments and clinical potential.
- Published in:
- Therapeutic Advances in Medical Oncology, 2016, v. 8, n. 3, p. 168, doi. 10.1177/1758834016631529
- By:
- Publication type:
- Article